glp-1 news insurers Insurance coverage just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. link in bio 🔗 GLP-1 Trends: Access & Shortages,

Latest study showing efficacy of nonpeptide oral GLP-1R agonists currently under development

Retatrutide: Why the Triple-Receptor Approach Is Getting Attention Retatrutide is attracting attention because it is being studied as a triple hormone receptor agonist

PubMed Central PMCID: PMC3119301

Patients should discuss the specific risks, benefits, and current availability of compounded medications directly with their prescribing clinician before beginning treatment, and should ask about whether an FDA-approved medication may be appropriate for their situation

The water strategy: Sipping small amounts of alkaline or room-temperature water throughout the day (rather than drinking large volumes at meals) dilutes stomach acid gently without increasing gastric volume at any single point

Sawicki T, Ruszkowska M, Danielewicz A, Niedwiedzka E, Arukowicz T, Przybyowicz KE